Professionals 217 Users Online

Bioinformatics Market

Advancements in Drug Development and Gene Therapy Driving Bioinformatics Market Growth

Bioinformatics Market by Type (Sequencing, Data Storage & Management, Data Analysis and Drug Discovery)

Bioinformatics Market Outlook (2023 to 2033)

Worldwide revenue from the bioinformatics market was about US$ 3.2 Billion in 2022, with the global market estimated to surge ahead at a CAGR value of 14.1% to reach a valuation of US$ 13.9 Billion by the end of 2033.

Bioinformatics Market Size (2022)

US$ 3.2 Billion

Projected Market Value (2033)

US$ 13.9 Billion

Global Market Growth Rate (2023 to 2033 )

14.1% CAGR

Market Share of Top 5 Countries


As assessed by Persistence Market Research, Bioinformatics market is expected to hold a market value of US$ 13.9 Billion by 2033.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Sales Analysis of Bioinformatics from 2014 to 2022 Vs Market Outlook for 2023 to 2033

The global market for Bioinformatics recorded a historic CAGR of 13.3% in the last 9 years from 2014 to 2022.

Bioinformatics, the fusion of biology and information technology is heavily utilised in the administration of biological data in the context of drug development and medical research. It has numerous uses in biology and medicine, including the discovery of drugs, gene therapy, forensic study of germs, molecular medicine, and preventative medicine. Techniques for protein functional and analysis, homology and similarity analysis, and sequence analysis are among the tools used in bioinformatics. Collection, annotation, storage, analysis, and retrieval of structural protein, and nucleic acid sequence data are some of the procedures used in bioinformatics.

COVID-19 had a significant impact on market growth in the beginning, but as vaccine research increased globally, genome sequencing and data analysis eventually proved to be too helpful for studying the environment and characterization of the genome. As a result, computational technology was heavily utilised across a number of research platforms. For public health control and containment measures, knowledge of transmission chains was essential, and understanding of virus diversity helped to design vaccinations and less expensive diagnostic techniques.

Many market participants offered to collaborate together. For instance, Illumina contributed cloud-based bioinformatics and sequencing supplies to Canadian COVID-19 projects in November 2021. The funds were given in support of the CanCoGen, or Canadian COVID-19 Genomics Network, projects HostSeq and VirusSeq.

The global bioinformatics market is thus likely to show high growth over the coming years a CAGR value of 14.1% and reach a global market size of US$ 13.9 Billion by 2033.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

How Can Bioinformatics Market Grow?

Increasing Collaborative Activities Among I.T. and Pharmaceutical Companies – Transforming Bioinformatics Sector

All through the anticipated period, the revenue growth in the bioinformatics market is anticipated to be boosted by the rapidly expanding collaborative activities, including collaborations and agreements entered into by (I.T.) information technology companies with pharmaceutical companies and clinical research organisations (CROs).Like in the case of online data storage and resource visualisation, the businesses formed partnerships in order to develop and advance important cloud-based healthcare solutions.

For instance, in order to penetrate the lucrative healthcare market, Amazon announced in June 2018 that it had purchased the online pharmacy company PillPack. The healthcare business strategy used by PillPack is providing patients with convenient dispensers together with pre-packaged prescription medications. The market for bioinformatics services is anticipated to grow as these IT and pharmaceutical industries collaborate more widely since it provides a vast platform for healthcare e-solutions. Furthermore, another key factor driving the rising growth of the bioinformatics market is the expanding utilisation of healthcare IT solutions in many research fields including cell signalling, gene receptor interactions, target differentiation, and route metabolism.

Academic and research institutes being one of the major revenue generating end use segment is anticipated to witness fastest growth during the forecast period due to rise in adoption of information technologies in distinct research areas such as genomics, metabolomics, proteomic and drug discovery programs carried out by various research institutes and universities.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Can Demand for Bioinformatics Market Be Affected in Any Way?

“Lack of Skilled Workers and Expensive Bioinformatics Tools”

Despite the fact that bioinformatics services have become a crucial component of research in the life sciences industry, a shortage of knowledgeable staff and experienced operators is predicted to impede the market's expansion. It is now crucial that bioinformatics approaches, such as genomic research or drug discovery, are carried out by qualified professionals as a result of the introduction of technological and procedural advancements in biotechnology. The expansion of bioinformatics services is being hampered by the growing requirement for significant expenditure in bioinformatics tool upgrading as well as installation training. This has led to a shortage of competent workers for bioinformatics service providers that can adapt to advanced bioinformatics processes and methodologies.

Additionally, because clinical laboratories place a great priority on automating operations, their ability to expand is constrained by a dearth of qualified workers in bioinformatics services.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Country-wise Insights

Why is the United States Bioinformatics Market Booming?

“Growing Requirement of Bioinformatics in Research and Development”

The United States accounted for 90.2% market share in the North America Bioinformatics market in 2022, and a similar trend is expected over the forecast period.

Due to strategic moves made by major participants in the American market, rising need for biomarkers and medication delivery methods, low sequencing costs, and significant technological breakthroughs, the United States has the largest application of bioinformatics in research and development. Because both new and existing applications are gaining traction, the growth curve for clinical applications in the bioinformatics market is moving upward.

For instance, Sure Select Human All Exon V8, a new exome design from Agilent Technologies, Inc., was released in June 2021. It delivers specialised content and up-to-date coverage of protein-coding regions from Refuses, CCDS, and GENCODE. It also contains difficult-to-capture exons and the TERT promoter, which are overlooked by rival exomes.

In order to assist with the collection and analysis of high-dimensional, multi-variant datasets related to drug development, such as microarrays, next-generation sequencing (NGS), proteomics, metabolomics, and epigenetics, as well as the related meta-data, Charles River entered into a strategic alliance with FiOS Genomics in January 2020.

Will Australia Be a Lucrative Market for Bioinformatics Service Providers?

“Rising Government Funding ”

Australia held around 74.9% market share of the Europe Bioinformatics market in 2022.

Over the coming years, the bioinformatics market in Australia is expected to experience tremendous growth. With several companies focusing on the development of cutting-edge platforms and tools, Australian bioinformatics companies are frequently viewed as being at the cutting edge of bioinformatics technology. Australia is home to a large number of prestigious research institutions that are actively involved in bioinformatics research, such as the Walter and Eliza Hall Institute and the Commonwealth Scientific and Industrial Research Organisation (CSIRO). This has helped the bioinformatics market in the nation grow. Additionally, the Australian government supports the bioinformatics industry in a number of ways, including through financing and grants, tax breaks, collaborative assistance, etc. A high-impact Cross-NCRIS data partnership project called OzBarley was successfully funded by an investment worth $4 Mn over two years from the Australian Research Data Commons (ARDC) thanks to a cross-NCRIS collaboration between Bioplatforms Australia and the Australian Plant Phenomics Facility (APPF).

How is Japan Emerging as a Prominent Market for Bioinformatics ?

“Use of Bioinformatics in the Field of Personalized Medicine”

Japan held the largest market share of about 50.2% of the East Asia Bioinformatics market in 2022.

Japan is home to the biggest bioinformatics database in Asia, therefore the industry will become more and more significant, particularly as it applies to the pharmaceutical and medical sectors. The growth curve for clinical applications in the bioinformatics market is moving upward. In recent years, product development has contributed to the market's expansion. This demonstrates the regulatory body's support for allowing certain products on the market. The public and private sectors' financial support will lead to an increase in bioinformatics start-ups and initiatives in the Japanese market. The money would help the institute's technical infrastructure advance and grow. This entails implementing fresh data storage systems and expanding the capacity of current data resources.

Category-wise Insights

Which Service Type is Driving Growth of the Global Bioinformatics Market?

“Precise Usage of Sequencing in Various Research Fields”

The sequencing segment held around 40.3% share of the total Bioinformatics market in 2022.

Factors such as the growing number of biotechnology and life science companies in developed regions (North America and Europe) and the growing demand for the development and manufacturing of biological products increases the growth of the drugs . Doctors recommend oral corticosteroids for patients who are losing their hair quickly and extensively. The oral medicine is reasonably priced but may have some negative effects. Metagenomics’ sequencing has recently been suggested as a method for identifying viral diseases. Applications of WGS in the clinic are anticipated to soon involve the creation of more precise maps of epidemic outbreaks. Hence it is one of the highly used service in the bioinformatics industry.

Which Application has the Most Prominent Use of Bioinformatics?

“Acquisition of Potential Information”

Microbial Genome Application segment accounted for 30.4% market value share in 2022. One of the precise and numerous uses of the usage of bioinformatics tool in the field of microbial genome application is the acquisition of scientific information with potential medicinal consequences, technical precision, and information of value.

Which End User Settings Pose a Greater Adoption Bioinformatics Services?

“Increased adoption of information technologies in specific research areas”

Academics and Research Centers hold a larger share of about 39.6% with a market value of US$ 1.2 Billion in 2022. Due to the increased adoption of information technologies in specific research areas like genomics, metabolomics, proteomics, and drug discovery programs carried out by various research institutes and universities, academic and research institutes, one of the major revenue-generating end use segments, are anticipated to experience fastest growth during the forecast period. The majority of these research initiatives are supported by either commercial companies or government funds. Bioinformatics research and development spending has increased, which has led to significant market growth.

Competitive Landscape

To strengthen service line around the globe, leading manufacturers are developing technologically advanced products. Similarly, several major competitors in the bioinformatics industry have engaged in consolidation activities such as mergers and acquisitions. Another significant approach noticed in the industry is the expansion of corporate collaborations in order to boost their Bioinformatics services.

For instance:

  • Rio, a bioinformatics pipeline and analytics platform providing better, quicker answers from next-generation sequencing tests, was introduced by ARUP in March 2022.
  • Sure Select Human All Exon V8, a novel exome design from Agilent Technologies, Inc., was made available in June 2021. It delivers precise content and coverage of protein-coding regions from Refuses, CCDS, and GENCODE. It also contains difficult-to-capture exons and the TERT promoter, which are overlooked by rival exomes.

Bioinformatics Industry Report Scope



Forecast Period

2023 to 2033

Historical Data Available for

2014 to 2022

Market Analysis

USD Billion for Value

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Türkiye
  • GCC
  • North Africa
  • South Africa

Key Market Segments Covered

  • Service Type
  • Application
  • End-User
  • Region

Key Companies Profiled

  • Illumina, Inc.
  • Thermo Fisher Scientific
  • Strand Life Sciences, Inc.
  • CD Genomics
  • Biomax Informatics AG
  • Agilent Technologies, Inc.
  • Gene Codes Corporation
  • BGI Group
  • Gene Code Corporation
  • PerkinElmer Inc.
  • Premier Biosoft
  • Biomatters Geneious
  • Creative-Biolabs
  • GSL Biotech LLC (SnapGene)

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments Covered in Bioinformatics Industry Research

Bioinformatics Market by Service Type:

  • Sequencing
  • Data Storage & Management
  • Data Analysis
  • Drug Discovery
  • Others

Bioinformatics Market by Application:

  • Drug Development
  • Molecular Medicine
  • Microbial Genome Applications
  • Gene Therapy
  • Veterinary Science
  • Forensic Analysis
  • Others

Bioinformatics Market by End User:

  • Academics and Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Forensics Laboratories
  • Others

Bioinformatics Market by Region:

  • North America Bioinformatics Market
  • Latin America Bioinformatics Market
  • Europe Bioinformatics Market
  • South Asia Bioinformatics Market
  • East Asia Bioinformatics Market
  • Oceania Bioinformatics Market
  • The Middle East & Africa Bioinformatics Market

- Companies Covered in This Report -

  • Illumina, Inc.
  • Thermo Fisher Scientific
  • Strand Life Sciences, Inc.
  • CD Genomics
  • Biomax Informatics AG
  • Agilent Technologies, Inc.
  • Gene Codes Corporation
  • BGI Group
  • Gene Code Corporation
  • PerkinElmer Inc.
  • Premier Biosoft
  • Biomatters Geneious
  • Creative-Biolabs
  • GSL Biotech LLC (SnapGene

- Frequently Asked Questions -

The global Bioinformatics market is currently valued at around US$ 3.2 Billion in 2022.

Sales of Bioinformatics market are set to witness a high growth rate of 14.1% and be valued at US$ 13.9 Billion by 2033.

Demand for Bioinformatics market increased at 13.3% CAGR from 2014 to 2022.

The US, Australia, Japan, Brazil, and GCC Countries account for most demand for Bioinformatics, currently holding 60.8% market share.

The U.S. accounts for around 90.2% share of the North American market.

Illumina, Inc., Thermo Fisher Scientific, Strand Life Sciences, Inc.  are the top three manufacturers of Bioinformatics products.

The China market held a share of about 34.3% in the East Asia Bioinformatics market in 2022, while India accounts for around 28.5% share.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate